Abstract

http://ssrn.com/abstract=1625028
 
 

References (33)



 


 



Cognition-Enhancing Drugs: Can We Say No?


Frank A. Pasquale III


University of Maryland Francis King Carey School of Law; Yale University - Yale Information Society Project

June 14, 2010

Bulletin of Science, Technology & Society, Vol. 30, No. 9, 2010

Abstract:     
Normative analysis of cognition-enhancing drugs frequently weighs the liberty interests of drug users against egalitarian commitments to a "level playing field." Yet those who would refuse to engage in neuroenhancement may well find their liberty to do so limited in a society where such drugs are widespread. To the extent that unvarnished emotional responses are world-disclosive, neurocosmetic practices also threaten to provide a form of faulty data to their users. This essay examines underappreciated liberty-based and epistemic rationales for regulating cognition-enhancing drugs.

Number of Pages in PDF File: 6

Keywords: cognition-enhancing drugs

working papers series





Download This Paper

Date posted: June 15, 2010  

Suggested Citation

Pasquale, Frank A., Cognition-Enhancing Drugs: Can We Say No? (June 14, 2010). Bulletin of Science, Technology & Society, Vol. 30, No. 9, 2010. Available at SSRN: http://ssrn.com/abstract=1625028 or http://dx.doi.org/10.2139/ssrn.1625028

Contact Information

Frank A. Pasquale III (Contact Author)
University of Maryland Francis King Carey School of Law ( email )
500 West Baltimore Street
Baltimore, MD 21201-1786
United States
410-706-4820 (Phone)
410-706-0407 (Fax)
Yale University - Yale Information Society Project ( email )
127 Wall Street
New Haven, CT 06511
United States
Feedback to SSRN


Paper statistics
Abstract Views: 857
Downloads: 118
Download Rank: 141,491
References:  33
Paper comments
No comments have been made on this paper

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo2 in 0.312 seconds